Corvel had its Relative Strength (RS) Rating upgraded from 80 to 83 Thursday.
IBD's unique rating measures market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the trailing 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history shows that the market's biggest winners often have an RS Rating of above 80 in the early stages of their moves.
Risk Management In The Stock Market: How Much Money To Invest Now
Corvel is not currently offering a proper buying opportunity. See if the stock goes on to form a chart pattern that could kick off a new price move.
Earnings growth rose last quarter from 18% to 39%, but revenue fell from 15% to 13%.
Corvel holds the No. 1 rank among its peers in the Commercial Services-Healthcare industry group. HealthStream and Premier Inc. are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
